PERSONALIZED IMMUNOTHERAPY IN SEPSIS: A MULTICENTRE AND MULTINATIONAL, DOUBLE-BLIND, DOUBLE-DUMMY RANDOMIZED CLINICAL TRIAL (THE IMMUNOSEP TRIAL)

HOME PAGE

Center:            Password:             

Notice: It is recommended that you should one of the following browsers: Microsoft Edge, Google Chrome and Opera. In some other browsers you may encounter difficulties when entering dates and times.